Anthony R. Cillo

Anthony R. Cillo

Auto-generated profile, based on publicly available information

Anthony R. Cillo

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAyana T. Ruffin
Ayana T. Ruffin
ACAnthony R. Cillo
Anthony R. Cillo
TTTracy Tabib
Tracy Tabib
ALAngen Liu
Angen Liu
SOSayali Onkar
Sayali Onkar
TBTullia C. Bruno
Tullia C. Bruno
Current immunotherapy paradigms aim to reinvigorate CD8+ T cells, but the contribution of humoral immunity to antitumor immunity remains understudied. Here, we demonstrate that in head and neck squamous cell carcinoma (HNSCC) caused by human papillomavirus infection (HPV+), patients have transcriptional signatures of germinal center (GC) tumor infiltrating B cells (TIL-Bs) and spatial organization of immune cells consistent with tertiary lymphoid structures (TLS) with GCs, both of which correlate with favorable outcome. GC TIL-Bs in HPV+ HNSCC are characterized by distinct waves of gene expression consistent with dark zone, light zone and a transitional state of GC B cells. Semaphorin 4a expression is enhanced on GC TIL-Bs present in TLS of HPV+ HNSCC and during the differentiation of TIL-Bs. Our study suggests that therapeutics to enhance TIL-B responses in HNSCC should be prioritized in future studies to determine if they can complement current T cell mediated immunotherapies.

17 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
CKCornelius H. L. Kürten
Cornelius H. L. Kürten
AKAditi Kulkarni
Aditi Kulkarni
ACAnthony R. Cillo
Anthony R. Cillo
PSPatricia M. Santos
Patricia M. Santos
ARAnna K. Roble
Anna K. Roble
RFRobert L. Ferris
Robert L. Ferris
Head and neck squamous cell carcinoma (HNSCC) is characterized by complex relations between stromal, epithelial, and immune cells within the tumor microenvironment (TME). To enable the development of more efficacious therapies, we aim to study the heterogeneity, signatures of unique cell populations, and cell-cell interactions of non-immune and immune cell populations in 6 human papillomavirus (HPV)+ and 12 HPV– HNSCC patient tumor and matched peripheral blood specimens using single-cell RNA sequencing. Using this dataset of 134,606 cells, we show cell type-specific signatures associated with inflammation and HPV status, describe the negative prognostic value of fibroblasts with elastic differentiation specifically in the HPV+ TME, predict therapeutically targetable checkpoint receptor-ligand interactions, and show that tumor-associated macrophages are dominant contributors of PD-L1 and other immune checkpoint ligands in the TME. We present a comprehensive single-cell view of cell-intrinsic mechanisms and cell-cell communication shaping the HNSCC microenvironment.

8 November 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
RPRonal M. Peralta
Ronal M. Peralta
BXBingxian Xie
Bingxian Xie
KLKonstantinos Lontos
Konstantinos Lontos
HNHector Nieves-Rosado
Hector Nieves-Rosado
KSKellie Spahr
Kellie Spahr
GDGreg M. Delgoffe
Greg M. Delgoffe
CD8+ T cells are critical mediators of antitumor immunity but differentiate into a dysfunctional state, known as T cell exhaustion, after persistent T cell receptor stimulation in the tumor microenvironment (TME). Exhausted T (Tex) cells are characterized by upregulation of coinhibitory molecules and reduced polyfunctionality. T cells in the TME experience an immunosuppressive metabolic environment via reduced levels of nutrients and oxygen and a buildup of lactic acid. Here we show that terminally Tex cells uniquely upregulate Slc16a11, which encodes monocarboxylate transporter 11 (MCT11). Conditional deletion of MCT11 in T cells reduced lactic acid uptake by Tex cells and improved their effector function. Targeting MCT11 with an antibody reduced lactate uptake specifically in Tex cells, which, when used therapeutically in tumor-bearing mice, resulted in reduced tumor growth. These data support a model in which Tex cells upregulate MCT11, rendering them sensitive to lactic acid present at high levels in the TME.

8 August 2024 in Cell
Verified
Journal Article
Closed access
ACAnthony R. Cillo
Anthony R. Cillo
CCCarly Cardello
Carly Cardello
FSFeng Shan
Feng Shan
LKLilit Karapetyan
Lilit Karapetyan
SKSheryl Kunning
Sheryl Kunning
DVDario A.A. Vignali
Dario A.A. Vignali

1 November 2014 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
ACAnthony R. Cillo
Anthony R. Cillo
DVDavid Vagratian
David Vagratian
MBMargaret A. Bedison
Margaret A. Bedison
EAElizabeth M. Anderson
Elizabeth M. Anderson
MKMary Kearney
Mary Kearney
JMJohn W. Mellors
John W. Mellors
A quantitative real-time PCR (qRT-PCR) assay with single-copy sensitivity targeting HIV-1gagRNA (thegagsingle-copy assay [gSCA]) has been used widely to quantify plasma viremia below the limit of detection of clinical assays in patients on effective antiretroviral therapy (ART), but viral RNA in 15 to 30% of samples amplifies inefficiently because of primer/probe mismatches. We sought to develop improved single-copy assays with increased sensitivity by improving nucleic acid recovery, designing qRT-PCR primers and a probe for a highly conserved region of integrase in the HIV-1polgene (the integrase single-copy assay [iSCA]), and increasing the plasma volume tested (Mega-iSCA). We evaluated gSCA versus iSCA in paired plasma samples from 10 consecutive patients with viremia of >1,000 copies/ml and 25 consecutive patients on suppressive ART. Three of 10 viremic samples amplified inefficiently with gSCA compared to the Roche Cobas Ampliprep/TaqMan 2.0, whereas all 10 samples amplified efficiently with iSCA. Among 25 samples from patients on suppressive ART, 8 of 12 samples that were negative for HIV-1 RNA by gSCA had detectable HIV-1 RNA by iSCA, and iSCA detected 3-fold or higher HIV-1 RNA levels compared to gSCA in 10 of 25 samples. Large-volume plasma samples (>20 ml) from 7 patients were assayed using Mega-iSCA, and HIV-1 RNA was quantifiable in 6, including 4 of 5 that were negative by standard-volume iSCA. These improved assays with superior sensitivity will be useful for evaluating whetherin vivointerventions can reduce plasma viremia and for assessing relationships between residual viremia and other virologic parameters, including the inducible proviral reservoir.

26 May 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SGStephanie Grebinoski
Stephanie Grebinoski
QZQianxia Zhang
Qianxia Zhang
ACAnthony R. Cillo
Anthony R. Cillo
SMSasikanth Manne
Sasikanth Manne
HXHanxi Xiao
Hanxi Xiao
DVDario A. A. Vignali
Dario A. A. Vignali